Business · 1 sources covering this

MakeMyTrip's India subsidiary receives Sebi approval to float IPO

Nasdaq-listed travel booking platform MakeMyTrip's India subsidiary has received Sebi's approval to launch an initial public offering (IPO), according to an update available on the markets regulator's website on Monday. MakeMyTrip (India) Ltd (MMT India) had filed draft papers with Sebi in July through the confidential route. After examining the draft documents, the regulator issued its final observations on November 6. Sebi's observations mark an important step in the IPO process, allowing the…

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
MakeMyTrip's India subsidiary receives Sebi approval to float IPO
Nasdaq-listed travel booking platform MakeMyTrip's India subsidiary has received Sebi's approval to launch an initial public offering (IPO), according to an update available on the markets regulator's website on Monday. MakeMyTrip (India) Ltd (MMT India) had filed draft papers with Sebi in July through the confidential route. After examining the draft documents, the regulator issued its final observations on November 6. Sebi's observations mark an important step in the IPO process, allowing the…
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/4a9cd678e79014ca817bba4902359dfa5f293954"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="MakeMyTrip's India subsidiary receives Sebi approval to float IPO"></iframe>

MakeMyTrip's India subsidiary receives Sebi approval to float IPO

How 1 sources are covering this

MakeMyTrip's India subsidiary receives Sebi approval to float IPO

More from Business

Early November trend indicates return of FPIs into Indian equities

Cancer drug price cuts take effect, set to save consumers ₹3,540 cr yearly

ZEEL extends gains, rises 11% in 2 days as board to mull buyback, dividend

PVR Inox rises 3% to 52-wk high as Ramayana's box-office biz tops ₹500 cr

Reader

Trust & legal

Across the network